Catalyst Wire Dossier Catalyst Wire Dossier

EluNIR Ridaforolimus-eluting stent

deforolimus (ridaforolimus) · Medinol Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EluNIR Ridaforolimus-eluting stent, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: BIONICS Small Vessels Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) in Coronary Stenosis Trial

See pricing